Keratin-positive giant cell-rich tumors of soft tissue with HMGA2::NCOR2 fusions

J Cutan Pathol. 2023 Nov;50(11):977-982. doi: 10.1111/cup.14497. Epub 2023 Jul 26.

Abstract

Background: Giant cell tumor of soft tissue (GCT-ST) is a rare soft tissue neoplasm that is morphologically similar to but genetically distinct from giant cell tumor of bone. A novel keratin-positive GCT-ST (KPGCT-ST) harboring HMGA2::NCOR2 fusions was recently discovered. Fewer than 30 cases have been described; herein is reported an additional seven.

Methods: Cases diagnosed as GCT-ST were retrieved from institutional archives and consultation files. The histopathologic characteristics were assessed, and the electronic medical record was reviewed.

Results: Seven tumors were identified in six women and one man with a median age of 23 years. All patients underwent excision; no recurrences or metastases were noted during a median follow-up period of 7 months. Histopathologically, the tumors were characterized by a multinodular proliferation of keratin-positive mononuclear cells with evenly admixed osteoclast-like giant cells and absent neoplastic bone. A fibrous capsule with lymphoid cuffing was frequently seen. Foamy macrophages, inflammation, hemorrhage, and hemosiderin were variably present. The HMGA2::NCOR2 fusion was detected in all cases.

Conclusions: Our findings support previously reported hypotheses that KPGCT-ST is a spectrum of the same entity as the recently described xanthogranulomatous epithelial tumor. Although follow-up data are limited, to date, KPGCT-ST appears to follow an indolent course.

Keywords: HMGA2; giant cell tumor; keratin; xanthogranulomatous epithelial tumor.

MeSH terms

  • Adult
  • Diagnosis, Differential
  • Female
  • Giant Cell Tumors* / pathology
  • Giant Cells / pathology
  • Humans
  • Keratins
  • Male
  • Nuclear Receptor Co-Repressor 2
  • Soft Tissue Neoplasms* / pathology
  • Young Adult

Substances

  • Keratins
  • NCOR2 protein, human
  • Nuclear Receptor Co-Repressor 2